Report: MLB is “actively going after” any players linked to the Biogenesis clinic

52 Comments

It was announced yesterday that Tigers minor league right-hander Cesar Carrillo was suspended 100 games for violating the minor league drug prevention and treatment program. No specific drug was mentioned in the announcement, but it was later confirmed that the suspension was the result of his connection to the Miami-based Biogenesis clinic. But there’s a whole lot more where that came from.

Ryan Braun, Alex Rodriguez, Melky Cabrera, Nelson Cruz, Gio Gonzalez, Jhonny Peralta, Yasmani Grandal, Francisco Cervelli, Bartolo Colon, Jesus Montero and Danny Valencia are among the major leaguers who have been linked to the clinic. MLB will obviously have a tougher time putting the hammer down on that group since they are protected by the union, but it’s clear that this story is far from over. It was reported earlier this week that the Florida Department of Health has opened an investigation into Biogenesis and Dr. Anthony Bosch, a potentially important development, but it remains to be seen whether they have any interest in cooperating with MLB.

Cubs won’t make Kyle Schwarber available in trade talks

Kyle Schwarber
Getty Images
Leave a comment

Bob Nightengale of USA Today reports that the Cubs won’t deal Kyle Schwarber this winter, despite multiple inquires from teams around the league. Schwarber is approaching his first year of arbitration and will remain under team control for another three seasons before reaching free agency in 2022.

The decision comes on the heels of one of the strongest seasons of the 25-year-old outfielder’s short career. Over 137 games and 510 PA for the Cubs, he proved a passable defender in left field and batted .238/.356/.467 with 26 home runs, an .823 OPS, and 3.2 fWAR in 2018. He also led the National League in intentional walks, with 20, and bumped up his total walks from 59 in 2017 to 78.

Despite his marked improvements from previous years, Schwarber’s performance still left something to be desired — specifically against left-handed pitchers, who held the slugger to a paltry .224/.352/.303 with four extra-base hits across 91 PA. Still, it’s evident the Cubs feel Schwarber is capable of strengthening his splits in the years to come, and they might stand to get more value from him on the field than they would in a trade this offseason.

Of course, that’s not to say the Cubs intend to pass the Winter Meetings in total silence, especially as they’ll be seeking bullpen and catching depth in advance of their 2019 run at the division title. As club president Theo Epstein remarked last week, “We’re certainly open and active in trade talks with a lot of deals that usually don’t come to fruition. So, we may make some trades. We could make big ones that transform the roster. We may make smaller complementary ones. But there’s certain things we’d like to accomplish.”